Alx Oncology Holdings Inc. (ALXO)
NASDAQ · Healthcare
Alx Oncology Holdings Inc. Revenue 2018–2022
Alx Oncology Holdings Inc. annual/quarterly revenue history and growth rate from 2018 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Alx Oncology Holdings Inc. revenue for the quarter ending June 30, 2020 was 527000, a 59.31% decrease year-over-year.
- Alx Oncology Holdings Inc. revenue for the twelve months ending June 30, 2020 was 3.7 M.
- Alx Oncology Holdings Inc. annual revenue for 2022 was 0.
- Alx Oncology Holdings Inc. annual revenue for 2021 was 0, a 100.00% decrease from 2020.
- Alx Oncology Holdings Inc. annual revenue for 2020 was 1.2 M, a 75.35% decrease from 2019.
- Alx Oncology Holdings Inc. annual revenue for 2019 was 4.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Alx Oncology Holdings Inc. (ALXO) — Frequently Asked Questions
Alx Oncology Holdings Inc. (ALXO) is a publicly traded US company. It has a market capitalization of $62M. Explore ALXO's stock price, financial statements, earnings history, margins and key ratios below.
What is Alx Oncology Holdings Inc.'s market cap?
Alx Oncology Holdings Inc. (ALXO) has a market capitalization of $62M.
What is the ALXO stock price?
ALXO trades at $1.52 (+4.11% on the day).
Is ALXO profitable?
In fiscal 2022, Alx Oncology Holdings Inc. reported net income of -$123M.